Literature DB >> 26742514

Huntington's Disease: Relationship Between Phenotype and Genotype.

Yi-Min Sun1, Yan-Bin Zhang2,3, Zhi-Ying Wu4.   

Abstract

Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disease with the typical manifestations of involuntary movements, psychiatric and behavior disorders, and cognitive impairment. It is caused by the dynamic mutation in CAG triplet repeat number in exon 1 of huntingtin (HTT) gene. The symptoms of HD especially the age at onset are related to the genetic characteristics, both the CAG triplet repeat and the modified factors. Here, we reviewed the recent advancement on the genotype-phenotype relationship of HD, mainly focus on the characteristics of different expanded CAG repeat number, genetic modifiers, and CCG repeat number in the 3' end of CAG triplet repeat and their effects on the phenotype. We also reviewed the special forms of HD (juvenile HD, atypical onset HD, and homozygous HD) and their phenotype-genotype correlations. The review will aid clinicians to predict the onset age and disease course of HD, give the genetic counseling, and accelerate research into the HD mechanism.

Entities:  

Keywords:  Genotype; Huntingtin; Huntington’s disease; Phenotype

Mesh:

Substances:

Year:  2016        PMID: 26742514     DOI: 10.1007/s12035-015-9662-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  98 in total

Review 1.  Genetic modifiers of Huntington's disease.

Authors:  James F Gusella; Marcy E MacDonald; Jong-Min Lee
Journal:  Mov Disord       Date:  2014-08-25       Impact factor: 10.338

2.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Trinucleotide repeat length and progression of illness in Huntington's disease.

Authors:  K Kieburtz; M MacDonald; C Shih; A Feigin; K Steinberg; K Bordwell; C Zimmerman; J Srinidhi; J Sotack; J Gusella
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

4.  CNR1 variation is associated with the age at onset in Huntington disease.

Authors:  Eugen Kloster; Carsten Saft; Jörg T Epplen; Larissa Arning
Journal:  Eur J Med Genet       Date:  2013-06-07       Impact factor: 2.708

5.  Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.

Authors:  M E MacDonald; J P Vonsattel; J Shrinidhi; N N Couropmitree; L A Cupples; E D Bird; J F Gusella; R H Myers
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

6.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.

Authors:  Erica Rockabrand; Natalia Slepko; Antonello Pantalone; Vidya N Nukala; Aleksey Kazantsev; J Lawrence Marsh; Patrick G Sullivan; Joan S Steffan; Stefano L Sensi; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

Review 7.  Animal models of Huntington's disease.

Authors:  Shilpa Ramaswamy; Jodi L McBride; Jeffrey H Kordower
Journal:  ILAR J       Date:  2007

Review 8.  Huntington's chorea. Report of 3 cases and review of the literature.

Authors:  J P Osborne; P Munson; D Burman
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

9.  Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease.

Authors:  S Furtado; O Suchowersky; B Rewcastle; L Graham; M L Klimek; A Garber
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

10.  Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range.

Authors:  K E De Rooij; P A De Koning Gans; M I Skraastad; R D Belfroid; M Vegter-Van Der Vlis; R A Roos; E Bakker; G J Van Ommen; J T Den Dunnen; M Losekoot
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

View more
  15 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

2.  Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.

Authors:  Huanhuan Luo; Liying Cao; Xuan Liang; Ana Du; Ting Peng; He Li
Journal:  Mol Neurobiol       Date:  2018-02-12       Impact factor: 5.590

Review 3.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

Review 4.  Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.

Authors:  Jana Miniarikova; Melvin M Evers; Pavlina Konstantinova
Journal:  Mol Ther       Date:  2018-02-08       Impact factor: 11.454

5.  Differential expression and roles of Huntingtin and Huntingtin-associated protein 1 in the mouse and primate brains.

Authors:  Xingxing Chen; Yize Sun; Laiqiang Chen; Xiu-Sheng Chen; Mingtian Pan; Yiran Zhang; Qi Wang; Weili Yang; Peng Yin; Dajian He; Xiangyu Guo; Su Yang; Yan Zeng; Sen Yan; Xiao-Jiang Li; Shihua Li
Journal:  Cell Mol Life Sci       Date:  2022-10-17       Impact factor: 9.207

6.  Propensity for somatic expansion increases over the course of life in Huntington disease.

Authors:  Radhia Kacher; François-Xavier Lejeune; Sandrine Noël; Cécile Cazeneuve; Alexis Brice; Sandrine Humbert; Alexandra Durr
Journal:  Elife       Date:  2021-05-13       Impact factor: 8.140

Review 7.  Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review.

Authors:  Shi-Shuang Cui; Ru-Jing Ren; Ying Wang; Gang Wang; Sheng-Di Chen
Journal:  BMC Neurol       Date:  2017-08-08       Impact factor: 2.474

Review 8.  Ubc13: the Lys63 ubiquitin chain building machine.

Authors:  Curtis D Hodge; Leo Spyracopoulos; J N Mark Glover
Journal:  Oncotarget       Date:  2016-09-27

9.  Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms.

Authors:  Francis Ramond; Isabelle Quadrio; Laurence Le Vavasseur; Hélène Chaumet; Fabrice Boyer; Muriel Bost; Elisabeth Ollagnon-Roman
Journal:  Mol Genet Genomic Med       Date:  2019-08-22       Impact factor: 2.183

10.  Preimplantation genetic testing for Huntington disease: the perspective of one Portuguese center.

Authors:  Diogo Ferreira; Berta Carvalho; Ana P Neto; Joaquina Silva; Ana M Póvoa; Alberto Barros; Filipa Carvalho
Journal:  Porto Biomed J       Date:  2019-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.